IP Library Granted Patent US 9,513,299
Granted Patent B2
US 9,513,299 · App. 13/619,620 · Granted Dec 6, 2016

Methods for the detection and diagnosis of malaria using an electrochemical sensor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,513,299
App. No.
13/619,620
Granted
Dec 6, 2016
Kind
B2
Abstract

Disclosed are apparatuses for detecting hemoglobin in patient samples. The apparatuses include a primary electrode and a reference electrode. The apparatus is configured to measure current or voltage generated between the primary electrode and the reference electrode in response a redox reaction catalyzed by hemoglobin. The apparatuses can detect a variety of hemoglobins, including dimeric hemoglobin associated with malaria. Also disclosed are biosensor systems including the apparatuses and methods of using the biosensor systems.

Claims (13)

1. An apparatus for detecting electrocatalytic activity of a hemoglobin sample, the apparatus comprising:

a first reaction cell including a first primary electrode and a first reference electrode electrically connected to the first primary electrode;

a second reaction cell including a second primary electrode and a second reference electrode electrically connected to the second primary electrode,

wherein the first and second primary electrode comprise a silicon wafer, a silicon dioxide layer, a titanium layer, a platinum layer, and a layer of metallic nickel nanoparticles,

wherein the silicon wafer is coated with the silicon dioxide layer, wherein the silicon dioxide layer is coated with the titanium layer, wherein the titanium layer is coated with the platinum layer, and wherein the platinum layer is coated with the layer of metallic nickel nanoparticles,

a measurement device configured to measure a current, voltage and/or resistance generated between the primary electrode and the reference electrode in response to a redox reaction of the hemoglobin sample in the first reaction cell and in the second reaction cell; and

a signal-displaying device configured to read the current, voltage and/or resistance measured by the measurement device and generate a readout indicating the presence or absence of malaria.

2. The apparatus of claim 1 , wherein the reference electrodes comprise an Ag/AgCl electrode.

3. The apparatus of claim 1 , wherein the reaction cell comprises a counter-electrode.

4. The apparatus of claim 3 , wherein the counter-electrode comprises a platinum wire.

5. The apparatus of claim 1 , wherein the measurement device comprises one or more of a volt meter or an ammeter.

6. The apparatus of claim 1 , wherein the measurement device is configured to compare the level of current, voltage and/or resistance of the hemoglobin sample to a control sample, and is configured to indicate the presence of malaria when a difference in the level of current, voltage and/or resistance is identified.

7. The apparatus of claim 1 , further comprising an inlet configured to contact the sample with the primary electrode.

Assignments (2)
SECURITY INTEREST Recorded Jan 29, 2019
From: EMPIRE TECHNOLOGY DEVELOPMENT LLC
To: CRESTLINE DIRECT FINANCE, L.P.
Reel/Frame 048373/0217 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 1, 2016
From: BHATTACHARYA, JAYDEEP
To: EMPIRE TECHNOLOGY DEVELOPMENT LLC
Reel/Frame 039062/0420 →